-+ 0.00%
-+ 0.00%
-+ 0.00%

Futura Medical Secures Chinese Patent for Erectile Dysfunction Treatment

MT Newswires·12/10/2025 05:00:03
Listen to the news
05:00 AM EST, 12/10/2025 (MT Newswires) -- Futura Medical (FUM.L) obtained a notice of patent allowance for its Eroxon medicine in China, with the intellectual property right valid until 2040. The British consumer healthcare group said Wednesday it plans to file a Chinese divisional patent in early 2026 to extend the protection for its erectile dysfunction treatment. Eroxon has existing patent protections in Europe, Hong Kong, Taiwan and the US.